Sutton Wealth Advisors Inc. Gilead Sciences, Inc. Transaction History

Sutton Wealth Advisors Inc.

$203 Billion
Q3 2023

A detailed history of Sutton Wealth Advisors Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sutton Wealth Advisors Inc. holds 318 shares of GILD stock, worth $30,909. This represents 0.01% of its overall portfolio holdings.

Number of Shares

318

Previous 368 13.59%

Holding current value

$30,909

Previous $28.4 Million 15.98%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $3,697 - $4,033	-50 Reduced 13.59%	318 $23.8 Million
Q2 2023 Nov 08, 2023	SELL	$76.01 - $86.7 $608 - $693	-8 Reduced 2.13%	368 $28.4 Million
Q1 2023 Nov 07, 2023	SELL	$77.31 - $88.08 $107,306 - $122,255	-1,388 Reduced 78.68%	376 $31.2 Million
Q4 2022 Nov 07, 2023	SELL	$62.32 - $89.47 $1,495 - $2,147	-24 Reduced 1.34%	1,764 $151 Million
Q3 2022 Nov 07, 2023	BUY	$59.54 - $68.01 $1,250 - $1,428	21 Added 1.19%	1,788 $110 Million
Q2 2022 Nov 07, 2023	BUY	$57.72 - $65.01 $692 - $780	12 Added 0.68%	1,767 $109 Million
Q1 2022 Nov 07, 2023	BUY	$57.92 - $72.58 $4,401 - $5,516	76 Added 4.53%	1,755 $104 Million
Q3 2021 Nov 07, 2023	BUY	$67.69 - $73.03 $338 - $365	5 Added 0.3%	1,679 $117 Million
Q1 2021 Nov 07, 2023	BUY	$60.0 - $68.46 $660 - $753	11 Added 0.66%	1,674 $108 Million
Q4 2020 Nov 07, 2023	BUY	$56.65 - $64.55 $2,889 - $3,292	51 Added 3.16%	1,663 $96.9 Million
Q3 2020 Nov 07, 2023	SELL	$62.1 - $78.08 $3,539 - $4,450	-57 Reduced 3.42%	1,612 $102 Million
Q2 2020 Nov 07, 2023	BUY	$72.34 - $84.0 $289 - $336	4 Added 0.24%	1,669 $128 Million
Q1 2020 Nov 07, 2023	BUY	$62.63 - $80.22 $3,319 - $4,251	53 Added 3.29%	1,665 $124 Million
Q4 2019 Nov 07, 2023	SELL	$61.62 - $67.78 $369 - $406	-6 Reduced 0.37%	1,612 $105 Million
Q2 2019 Nov 06, 2023	BUY	$61.87 - $69.38 $247 - $277	4 Added 0.25%	1,618 $109 Million
Q1 2019 Nov 06, 2023	BUY	$62.53 - $70.05 $875 - $980	14 Added 0.88%	1,614 $105 Million
Q3 2018 Nov 06, 2023	SELL	$71.28 - $78.92 $498 - $552	-7 Reduced 0.44%	1,600 $124 Million
Q2 2018 Nov 06, 2023	SELL	$64.88 - $75.68 $259 - $302	-4 Reduced 0.25%	1,607 $114 Million
Q4 2017 Nov 06, 2023	BUY	$71.15 - $83.52 $426 - $501	6 Added 0.37%	1,611 $115 Million
Q3 2017 Nov 06, 2023	SELL	$72.11 - $85.47 $1,225 - $1,452	-17 Reduced 1.05%	1,605 $130 Million
Q2 2017 Nov 06, 2023	BUY	N/A	64 Added 4.11%	1,622 $115 Million
Q1 2017 Nov 06, 2023	SELL	N/A	-185 Reduced 10.61%	1,558 $106 Million
Q4 2016 Nov 06, 2023	BUY	N/A	149 Added 9.35%	1,743 $125 Million
Q3 2016 Nov 06, 2023	SELL	N/A	-73 Reduced 4.38%	1,594 $126 Million
Q2 2016 Nov 06, 2023	SELL	N/A	-678 Reduced 28.91%	1,667 $139 Million
Q1 2016 Nov 06, 2023	BUY	N/A	2,345	2,345 $215 Million

Others Institutions Holding GILD

# of Institutions

1,963

Shares Held

995M

Call Options Held

10.5M

Put Options Held

9.86M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $122B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.

Account

Sutton Wealth Advisors Inc. Gilead Sciences, Inc. Transaction History